| 摘要 |
Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, and R6 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating obesity and related diseases, disorders, and conditions associated with MetAP2. |
| 申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED;CHERUVALLATH, ZACHARIA;ERICKSON, PHILIP;FENG, JUN;KOMANDLA, MALLAREDDY;LAWSON, JOHN DAVID;MCBRIDE, CHRISTOPHER;MIURA, JOANNE;MURPHY, SEAN;TANG, MINGNAM;TON-NU, HUONG-THU |
发明人 |
CHERUVALLATH, ZACHARIA;ERICKSON, PHILIP;FENG, JUN;KOMANDLA, MALLAREDDY;LAWSON, JOHN DAVID;MCBRIDE, CHRISTOPHER;MIURA, JOANNE;MURPHY, SEAN;TANG, MINGNAM;TON-NU, HUONG-THU |
